• Lomustine is FDA approved as a secondary therapy in combination with other drugs to treat people with Hodgkin lymphoma who relapse while being treated with primary therapy or who fail to respond to primary therapy. (lls.org)
  • Lomustine belongs to a class of drugs known as alkylating agents. (medhelp.org)
  • Lomustine belongs to the category of antitumor drugs that have a so-called alkylating action. (treat-simply.com)
  • Using lomustine may increase your risk of developing other types of cancer, such as leukemia. (wellspan.org)
  • There is a slight risk of developing a blood cancer such as leukemia years after taking lomustine. (chemocare.com)
  • Pulmonary toxicity (damage to the lungs) is uncommon in low doses of lomustine. (chemocare.com)
  • Your doctor will check your lung function prior to the start lomustine and will order periodic checks (pulmonary function tests), particularly if you are receiving high doses of lomustine. (chemocare.com)
  • The amount of lomustine that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated. (chemocare.com)
  • Lomustine works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication. (actizapharmaceutical.com)
  • Your doctor may tell you to take the medicine at bedtime to keep you from having nausea. (umm.edu)
  • The German pharmaceutical company Medak GmbH is the owner of the registration certificate for lomustine drug. (treat-simply.com)
  • Pharmaceutical companies of another German company - Haupt Pharma Amareg GmbH - are issuing the drug lomustine. (treat-simply.com)
  • Having overcome the blood-brain barrier, the drug penetrates into breast milk and into the cerebrospinal fluid( in it, its concentration is more than half the value achieved in blood plasma).Metabolism( the conversion of the active substance into soluble forms) of lomustine occurs in the structures of the liver. (treat-simply.com)